IcoCell− Chassis for Enhanced Mammalian Cell Line Development and Engineering

Informazioni relative al progetto

IcoCell

ID dell’accordo di sovvenzione: 663613

DOI 10.3030/663613

Progetto chiuso

Data della firma CE 16 Marzo 2015

Data di avvio 1 Aprile 2015

Data di completamento 30 Settembre 2015

Finanziato da

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology

Costo totale € 71 429,00

Contributo UE € 50 000,00

Coordinato da

ICOSAGEN CELL FACTORY OU
Estonia

Obiettivo

The opportunity to focus on the production of biopharmaceuticals is often taken from SMEs since huge amount of resources is required for the development of high-producer cell lines. We envision that our parental cell factories will increase the efficiency of cell line engineering and will effectively reduce the time-to-market for mammalian cell-based products. It allows SMEs to leverage their traditional strengths of adaptability and creativity, and to develop novel products for biotechnology industries.

Campo scientifico

• natural sciences › biological sciences › biochemistry › biomolecules › proteins

Programma(i)

• H2020-EU.2.1.4. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Argomento(i)

• BIOTEC-5a-2014-1 - SME boosting biotechnology-based industrial processes driving competitiveness and sustainability

Invito a presentare proposte

H2020-SMEInst-2014-2015

Vedi altri progetti per questo bando

Bando secondario

H2020-SMEINST-1-2014

Meccanismo di finanziamento

SME-1 - SME instrument phase 1

Coordinatore

ICOSAGEN CELL FACTORY OU

• Contribution nette de l'UE: € 50 000,00
• Indirizzo: EERIKA TEE 1 ; 61713 Kambja Vald ; Estonia
• PMI L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione. Sì:
  Regione
  Eesti › Eesti › Lõuna-Eesti
• Regione: Eesti › Eesti › Lõuna-Eesti
• Tipo di attività: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Costo totale: € 71 429,00